24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
55.45% |
|
ENZYME DYNAMICS |
17.27% |
|
PEPTIDOMIMETIC CD40L BINDING |
14.55% |
|
ALZHEIMERS |
12.73% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
66.12% |
|
ALZHEIMERS |
16.27% |
|
PEPTIDOMIMETIC CD40L BINDING |
14.79% |
|
ENZYME DYNAMICS |
2.81% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
33.22% |
|
ENZYME DYNAMICS |
26.48% |
|
PEPTIDOMIMETIC CD40L BINDING |
15.47% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
13.28% |
|
ALZHEIMERS |
5.19% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
5.1% |
|
ATSTP10 SUCROSE TRANSPORT |
.76% |
|
MEMBRANE TRANSPORT |
.34% |
|
NIPAH VIRUS DECOY PROTEINS |
.17% |